David Rescott
Stock Analyst at Baird
(3.51)
# 855
Out of 4,893 analysts
61
Total ratings
56%
Success rate
4.09%
Average return
Main Sectors:
Top Industries:
Stocks Rated by David Rescott
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
HAE Haemonetics | Initiates: Outperform | $87 | $78.17 | +11.30% | 1 | Jun 26, 2025 | |
MDT Medtronic | Maintains: Neutral | $94 → $92 | $89.40 | +2.91% | 6 | May 22, 2025 | |
LIVN LivaNova | Maintains: Outperform | $55 → $61 | $46.78 | +30.40% | 4 | May 8, 2025 | |
MMSI Merit Medical Systems | Maintains: Outperform | $111 → $110 | $95.13 | +15.63% | 3 | Apr 25, 2025 | |
PEN Penumbra | Maintains: Buy | $315 → $330 | $243.87 | +35.32% | 29 | Apr 24, 2025 | |
EW Edwards Lifesciences | Maintains: Neutral | $72 → $75 | $78.80 | -4.82% | 4 | Apr 24, 2025 | |
BSX Boston Scientific | Maintains: Outperform | $115 → $120 | $103.86 | +15.54% | 5 | Apr 24, 2025 | |
ISRG Intuitive Surgical | Maintains: Outperform | $600 → $575 | $526.05 | +9.31% | 3 | Apr 23, 2025 | |
SIBN SI-BONE | Maintains: Buy | $25 → $26 | $18.80 | +38.30% | 6 | Dec 22, 2023 |
Haemonetics
Jun 26, 2025
Initiates: Outperform
Price Target: $87
Current: $78.17
Upside: +11.30%
Medtronic
May 22, 2025
Maintains: Neutral
Price Target: $94 → $92
Current: $89.40
Upside: +2.91%
LivaNova
May 8, 2025
Maintains: Outperform
Price Target: $55 → $61
Current: $46.78
Upside: +30.40%
Merit Medical Systems
Apr 25, 2025
Maintains: Outperform
Price Target: $111 → $110
Current: $95.13
Upside: +15.63%
Penumbra
Apr 24, 2025
Maintains: Buy
Price Target: $315 → $330
Current: $243.87
Upside: +35.32%
Edwards Lifesciences
Apr 24, 2025
Maintains: Neutral
Price Target: $72 → $75
Current: $78.80
Upside: -4.82%
Boston Scientific
Apr 24, 2025
Maintains: Outperform
Price Target: $115 → $120
Current: $103.86
Upside: +15.54%
Intuitive Surgical
Apr 23, 2025
Maintains: Outperform
Price Target: $600 → $575
Current: $526.05
Upside: +9.31%
SI-BONE
Dec 22, 2023
Maintains: Buy
Price Target: $25 → $26
Current: $18.80
Upside: +38.30%